PRK 124

PRK 124 - one of Senetek's second generation isoprenoid cytokinins, has successfully completed clinical testing for the treatment of the signs of aging and effectiveness in reducing erythema, skin redness caused by increased blood flow to capillaries. A second clinical trial for the treatment of acne rosacea is nearing completion.